Neprilysin protects human neuronal progenitor cells against impaired development caused by amyloid-β peptide

Brain Research

Volumn 1124, Issue 1, 2006, Pages 10-18

  Mazur Kolecka, Bozena ^a   Frackowiak, Janusz ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Amyloidosis ; Cell culture; Neprilysin; Neuronal progenitor cells; Neuroreplacement therapy

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; ENZYME INHIBITOR; MEMBRANE METALLOENDOPEPTIDASE; PHOSPHORAMIDON;

ADOPTIVE IMMUNOTHERAPY; AMYLOIDOSIS; ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DRUG EFFECT; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; NERVE CELL CULTURE; NERVE CELL DIFFERENTIATION; NERVE CELL GROWTH; NEURAL STEM CELL; NEUROPROTECTION; OXIDATIVE STRESS; PRIORITY JOURNAL;

AMYLOID BETA-PROTEIN; BROMODEOXYURIDINE; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; DRUG INTERACTIONS; FETUS; GLYCOPEPTIDES; HUMANS; IMMUNOHISTOCHEMISTRY; NEPRILYSIN; NERVE TISSUE PROTEINS; NEURONS; NEUROPROTECTIVE AGENTS; PEPTIDE FRAGMENTS; PROTEASE INHIBITORS; STEM CELLS; TIME FACTORS;

EID: 33751173622     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.09.064     Document Type: Article

References (52)

1. Akiyama H., Kono H., Ikeda K., Kato M., and McGeer P.L. Immunohistochemical localization of neprilysin in the human cerebral cortex: inverse association with vulnerability to amyloid β-protein (Aβ) deposition. Brain Res. 902 (2001) 277-281
2. Arsenijevic Y., Villemure J.G., Brunet J.F., Bloch J.J., Degion N., Kostic C., Zum A., and Aebischer P. Isolation of multipotent neural precursors residing in cortex of the adult human brain. Exp. Neurol. 170 (2001) 48-62
3. Butterfield A.D., Castegna A., Lauderback C.M., and Drake J. Evidence the amyloid-beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death. Neurobiol. Aging 23 (2002) 655-664
4. Cao Q., Benton R.L., and Whittemore S.R. Stem cell repair of central nervous system injury. J. Neurosci. Res. 68 (2002) 501-510
5. Carpentier M., Robitaille Y., DesGroseillers L., Boileau G., and Marcinkiewicz M. Declining expression of neprilysin in Alzheimer disease: possible involvement in cerebral amyloid angiopathy. J. Neuropathol. Exp. Neurol. 61 (2002) 849-856
6. Frackowiak J., Mazur-Kolecka B., Wisniewski H.M., Potempska A., Carrol R.T., Emmerling M.R., and Kim K.S. Secretion and accumulation of Alzheimer's β-protein by cultured vascular smooth muscle cells from old and young dogs. Brain Res. 676 (1995) 225-230
7. Frackowiak J., Miller D.L., Potempska A., Sukontasup T., and Mazur-Kolecka B. Secretion and accumulation of Aβ by brain vascular smooth muscle cells from AβPP-Swedish transgenic mice. J. Neuropathol. Exp. Neurol. 62 (2003) 685-696
8. Gage F.H. Mammalian neuronal stem cells. Science 287 (2000) 1433-1438
9. Gage F.H., Coates P.W., Palmer T.D., Kuhn H.G., Fisher L.J., Suhonen J.O., Peterson D.A., Suhr S.T., and Ray J. Survival and differentiation of adult neural progenitor cells transplanted to the adult brain. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 11879-11883
10. Gouras G.K., Tsai J., Naslund J., Vincent B., Edgar M., Checler F., Greenfield J.P., Haroutunian V., Buxbaum J.D., Xu H., Greengard P., and Relkin N.R. Intraneuronal Abeta 42 accumulation in human brain. Am. J. Pathol. 156 (2000) 15-20
11. Hama E., Shirotani K., Masumoto H., Sekine-Aizawa Y.Y., Aizawa H., and Saido T.C. Clearance of extracellular and cell-associated amyloid beta peptide through viral expression of neprilysin in primary neurons. J. Biochem. 130 (2001) 721-726
12. Harper J.D., Wong S.S., Lieber C.M., and Lansbury Jr. P.T. Assembly of Aβ amyloid protofibrils: an in vitro model for a possible early event in Alzheimer's disease. Biochemistry 38 (1999) 8972-8980
13. Haughey N.J., Liu D., Nath A., Borchard A.C., and Mattson M.P. Disruption of neurogenesis in the subventricular zone of adult mice, and in human cortical neuronal precursor cells in culture, by amyloid beta-peptide: implications for the pathogenesis of Alzheimer's disease. Neuromol. Med. 1 (2002) 125-135
14. Haughey N.J., Nath A., Chan S.L., Borchard A.C., Rao M.S., and Mattson M.P. Disruption of neurogenesis by amyloid β-peptide, and perturbed neural progenitor cell homeostasis, in models of Alzheimer's disease. J. Neurochem. 83 (2002) 1509-1524
15. Hensley K., Carney J.M., Mattson M.P., Aksenova M., Harris M., Wu J.F., Floyd R.A., and Butterfield D.A. A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 1270-1274
16. Iwata N., Tsubuki S., Takaki Y., Watanabe K., Sekiguchi M., Hosoki E., Kawashima-Morishima M., Lee H.-J., Hama E., Sekine-Aizawa Y., and Saido T.C. Identification of the major Aβ1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat. Med. 6 (2000) 143-150
17. Iwata N., Takaki Y., Fukami S., Tsubuki S., and Saido T.C. Region-specific reduction of Abeta-degrading endopeptidase, neprilysin, in mouse hippocampus upon aging. J. Neurosci. Res. 70 (2002) 493-500
18. Iwata N., Mizukami H., Shirotani K., Takaki Y., Muramatsu S., Lu B., Gerard N.P., Gerard C., Ozawa K., and Saido T.C. Presynaptic localization of neprilysin contributes to efficient clearance of amyloid-β peptide in mouse brain. Neurobiol. Dis. 24 (2004) 991-998
19. Jankovski A., Garcia C., Soriano E., and Sotelo C. Proliferation, migration and differentiation of neuronal progenitor cells in the adult mouse subventricular zone surgically separated from its olfactory bulb. Eur. J. Neurosci. 10 (1998) 3853-3868
20. Jin K., Peel A.L., Mao X.O., Cottrell B.A., Henshall D.C., and Greenberg D.A. Increased hippocampal neurogenesis in Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 343-347
21. Kanemitsu H., Tomiyama T., and Mori H. Human neprilysin is capable of degrading amyloid β peptide not only in the monomeric form but also the pathological oligomeric form. Neurosci. Lett. 350 (2003) 113-116
22. Kayed R., Head E., Thompson J.L., McIntire T.M., Milton S.C., Cotman C.W., and Glabe C.G. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300 (2003) 486-489
23. Klein W.L. Abeta toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets. Neurochem. Int. 41 (2002) 345-352
24. Lopez-Toledano M.A., and Shelanski M.L. Neurogenic effect of β-amyloid peptide in the development of neural stem cells. J. Neuroimmunol. 24 (2004) 5439-5444
25. Lorenzo A., and Yankner B.A. β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 12243-12247
26. Marr R.A., Rockenstein E., Mukherjee A., Kindy M.S., Hersh L.B., and Gage F.H. Neprylysin gene transfer reduces human amyloid pathology in transgenic mice. J. Neurosci. 23 (2003) 1992-1996
27. Mattson M.P. Emerging neuroprotective strategies for Alzheimer's disease: dietary restriction, telomerase activation, and stem cell therapy. Exp. Gerontol. 35 (2000) 489-502
28. Mazur-Kolecka B., Frackowiak J., Le Vine H., Haske T., Evans L., Krzeslowska J., and Golabek A. TGF-β1 enhances formation of cellular Aβ/apoE deposits in vascular myocytes. Neurobiol. Aging 24 (2003) 355-364
29. Mazur-Kolecka B., Dickson D., and Frackowiak J. Induction of vascular amyloidosis-β by oxidative stress depends on APOE genotype. Neurobiol. Aging 27 (2006) 804-814
30. Mazur-Kolecka B., Golabek A., Nowicki K., Flory M., and Frackowiak J. Amyloid-β impairs development of neuronal progenitor cells by oxidative mechanisms. Neurobiol. Aging 27 (2006) 1181-1192
31. McKeown D.A., Doty R.L., Perl D.P., Frye R.E., Simms I., and Mester A. Olfactory function in young adolescent with Down's syndrome. J. Neurol., Neurosurg. Psychiatry 1 (1996) 412-414
32. Murphy C. Loss of olfactory function in dementing disease. Physiol. Behav. 66 (1999) 177-182
33. Murphy C., and Jinich S. Olfactory dysfunction in Down's syndrome. Neurobiol. Aging 17 (1996) 631-637
34. Oefner C., D'Arcy A., Henning M., Winkler F.K., and Dale G.E. Structure of human neutral endopeptidase (neprilysisn) complexed with phosphoramidon. J. Mol. Biol. 296 (2000) 341-349
35. Oliveira Jr. A.A., and Hodges H.M. Alzheimer's disease and neuronal transplantation as prospective cell therapy. Curr. Alzheimer's Res. 2 (2005) 79-95
36. Potempska A., Mack K., Mehta P., Kim K.S., and Miller D.L. Quantitation of sub-femtomole amount of Alzheimer amyloid β peptides. Amyloid 6 (1999) 14-21
37. Qian X., Shen Q., Goderie S.K., He W., Capela A., Davis A.A., and Temple S. Timing of CNS cell generation: a programmed sequence of neuron and glial cell production from isolated murine cortical stem cells. Neuron 28 (2000) 69-80
38. Saido T.C. Degradation of amyloid β peptide: a key to Alzheimer pathogenesis, prevention and therapy. NeuroSci. News 3 (2000) 52-62
39. Serby M. Olfaction and Alzheimer's disease. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 10 (1986) 579-586
40. Shirotani K., Tsubuki S., Iwata N., Takaki Y., Harigaya W., Maruyama K., Kiryu-Seo S., Kiyama H., Iwata H., Tomita T., Iwatsubo T., and Saido T.C. Neprilysin degrades both amyloid-β peptides 1-40 and 1-42 most rapidly and efficiently among thiorphan- and phosphoramidon-sensitive endopeptidases. J. Biol. Chem. 276 (2001) 21895-21901
41. Solan N.J., Ward P.E., Sanders S.S., Towns M.C., and Bathon J.M. Soluble recombinant neutral endopeptidase (CD10) as a potential anti-inflammatory agent. Inflammation 22 (1998) 107-120
42. Sugaya K. Possible use of autologous stem cell therapies for Alzheimer's disease. Curr. Alzheimer's Res. 2 (2005) 367-376
43. Sugaya K., and Brannen C.L. Stem cell strategies for neuroreplacement therapy in Alzheimer's disease. Med. Hypotheses 57 (2001) 697-700
44. Svendsen C.N., Borg M.G., Armstrong R.J.E., Rosser A.E., Chandran S., Ostenfeld T., and Caldwell M.A. A new method for the rapid and long-term growth of human neuronal precursor cells. J. Neurosci. Methods 85 (1998) 141-152
45. Talamo B.R., Rudel R.A., Kosik K.S., Lee V., Neff S., Adelman L., and Kauer J.S. Pathological changes in olfactory neurons in patients with Alzheimer's disease. Nature 337 (1989) 736-739
46. Temple S., and Alvarez-Buylla A. Stem cells in the adult mammalian central nervous system. Curr. Opin. Neurobiol. 9 (1999) 135-141
47. Turner A.J. Neprilysin. In: Barrett A.J., Rawlings N.D., and Woessner J.F. (Eds). Handbook of Proteolytic Enzymes (1998), Academic Press, San Diego 1080-1085
48. Turner A.J., and Tanzawa K. Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX. FASEB J. 11 (1997) 355-364
49. Vescovi A.L., Gritti A., Galli R., and Parati E.A. Isolation and intracerebral grafting of nontransformed multipotential embryonic human CNS stem cells. J. Neurotrauma 16 (1999) 689-693
50. Walsh D.M., Hartley D.M., Kusumoto Y., Fezoui Y., Condron M.M., Lomakin A., Benedek G.B., Selkoe D.J., and Teplow D.B. Amyloid β-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J. Biol. Chem. 274 (1999) 25945-25952
51. Wisniewski H.M., Wegiel J., and Popovitch E.R. Age-associated development of diffuse and thioflavin S-positive plaques in Down syndrome. Dev. Brain Dysfunct. (1994) 330-339
52. Zucco G.M., and Negrin N.S. Olfactory deficits in Down subjects: a link with Alzheimer disease. Percept. Mot. Skills 78 (1994) 627-631